Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.
Clinical trial NCT07309822 · RECRUITING
Trial details
- NCT number
- NCT07309822
- Sponsor
- Probelte Pharma S.L.U.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-01
- Primary completion
- 2031-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.